This is an auto-generated stub page built from atlas entry frontmatter. A richer
hand-crafted page is planned. See the
atlas source
for the full entry including detailed body sections.
gastric-cancer
Gastric Cancer
HER2 overexpression (~15-20%) and MSI-H (~10-15%) define actionable subsets; pembrolizumab is first-line for PD-L1+ gastric cancer; trastuzumab+chemotherapy is standard for HER2+ disease; ramucirumab (VEGFR2) and zolbetuximab (CLDN18.2) are approved in later lines.
Entry Metadata
| Field | Value |
|---|---|
| ID | gastric-cancer |
| Name | Gastric Cancer |
| Status | draft |
| Last reviewed | 2026-06-06 |
| Atlas | 01-human |
| Scale | 07-system |
Cross-Atlas Connections
connects-toHer2
connects-toVegf
connects-toPd 1
connects-toEgfr
connects-toHelicobacter Pylori
connects-toEpstein Barr Virus
connects-toHereditary Diffuse Gastric Cancer
connects-toCholangiocarcinoma
connects-toStomach
connects-toEsophageal Cancer
connects-toColorectal Cancer
connects-toLynch Syndrome
connects-toIron Deficiency Anemia
connects-toFap
connects-toGist
connects-toCdh1
connects-toP53
connects-toKras
connects-toMacrophage
connects-toDigestive System
connects-toIntestinal Epithelium
connects-toPhoton
connects-toT Cytotoxic Cell
connects-toLiver
connects-toOvarian Cancer
connects-toSodium
connects-toFgfr
connects-toFibroblast
connects-toNitrogen
connects-toNf Kb
connects-toRegulatory T Cell
connects-toIron
connects-toPancreas
connects-toFibrosis
connects-toEndothelial Cell
connects-toLarge Intestine
connects-toBone Marrow
connects-toElectron
connects-toSkin
connects-toLung
connects-toAntibody
connects-toErythrocyte
connects-toNeuron
connects-toReproductive System
connects-toMet
connects-toPlatelet
connects-toPik3Ca
connects-toDendritic Cell
connects-toBreast Cancer
connects-toMlh1
connects-toMast Cell
connects-toVenous Thromboembolism
connects-toStat3
connects-toSepsis
connects-toAnemia Of Chronic Disease
connects-toCkd
connects-toHeart Failure
connects-toMajor Depressive Disorder
connects-toOsteoporosis
connects-toNeuropathic Pain
connects-toAspergillus Fumigatus
connects-toWound Healing
connects-toEndocrine System
connects-toGeneralized Anxiety Disorder
connects-toLymphatic System
connects-toIntegumentary System
connects-toImmune System
connects-toNervous System
connects-toRespiratory System
connects-toMusculoskeletal System
connects-toCheckpoint Inhibitors
connects-toCancer Chemotherapy
connects-toTargeted Therapy
connects-toHepatic Lobule
connects-toCortical Bone
connects-toPancreatic Cancer
connects-toAlveolus
connects-toGerminal Center
connects-toEndometrial Cancer
connects-toDlbcl
connects-toNeuroendocrine Tumors
connects-toObesity
connects-toPeutz Jeghers Syndrome
connects-toJuvenile Polyposis Syndrome
connects-toWnt Beta Catenin
connects-toAkt
connects-toMyc
connects-toHif 1Alpha
connects-toTgf Beta
connects-toTert
connects-toCcl2
connects-toTlr4
connects-toCgas Sting
connects-toCxcl12
connects-toLmp1
connects-toCaspase 3
connects-toPerforin
connects-toErk1 2
connects-toMtor
connects-toIl 1B
connects-toMyd88
connects-toIl 6
connects-toCdkn2A
connects-toJak1 2
connects-toGalectin 3
connects-toSmad4
connects-toStat1
connects-toEzh2
connects-toCdk4 6
connects-toFoxo
connects-toS100A8 A9
connects-toMdm2
connects-toGsk 3B
connects-toSrc Kinase
connects-toDnmt3A
connects-toAmpk
connects-toAutophagy
connects-toCcr5
connects-toArid1A
connects-toIl 33
connects-toIl 17A
connects-toComplement C3
connects-toCalcineurin
connects-toOsteopontin
connects-toMhc Class Ii
connects-toProton
connects-toAxl Receptor
connects-toHemoglobin
connects-toIl 2
connects-toXanthine Oxidase
connects-toProstaglandins
connects-toIl 10
connects-toIron
connects-toIl 4
connects-toIl 13
connects-toLeptin
connects-toAdiponectin
connects-toResistin
connects-toHepcidin
connects-toB Cell
connects-toSecretory Iga
connects-toIfn Gamma
connects-toIl 12
connects-toType I Interferon
connects-toIl 5
connects-toIl 23
connects-toIge
connects-toPlasma Cell
connects-toNatural Killer Cell
connects-toT Helper Cell
connects-toC5Ar1
connects-toComplement C5
connects-toFactor H
connects-toTransferrin
connects-toTslp
connects-toBradykinin
connects-toErythropoietin
connects-toHistamine
connects-toMelatonin
connects-toTestosterone
connects-toProlactin
connects-toOxytocin
connects-toVasopressin
connects-toSerotonin
connects-toSelenium
connects-toIodine
connects-toMagnesium
connects-toCopper
connects-toZinc
connects-toCalcium
connects-toPhosphorus
connects-toPotassium
connects-toCarbon
connects-toChloride
connects-toHydrogen
connects-toGlp 1
connects-toAngiotensin Ii
connects-toRankl
connects-toFibronectin
connects-toNotch
connects-toIgf 1
connects-toActivin A
connects-toCgrp
connects-toCalcitonin
connects-toSubstance P
connects-toInsulin Receptor
connects-toAldosterone
connects-toAndrogen Receptor
connects-toNorepinephrine
connects-toAdrenomedullin
connects-toBdnf
connects-toEpinephrine
connects-toRenin
Sources
- Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376(9742):687-697. · PubMed 20728210
- Janjigian YY, Shitara K, Moehler M, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649). Lancet. 2021;398(10294):27-40. · PubMed 34102137